[Retracted] Implications of Ezetimibe in Combination with Low- to Moderate-Intensity Atorvastatin Adjuvant Aspirin Therapy for Cerebrovascular Disease

Table 5

Comparison of adverse rates as well as recurrence rates in the 2 groups (cases, %).

Group	Cases ()	Nausea and vomiting	Poor appetite	Muscle pain	Adverse reaction rates
Control group	55	2	1	2	5 (9.09)
Study group	55	1	1	0	2 (3.63)
					1.373
					0.241